In their study, the CES1P1 rs7187684-T allele could elevate the possibility of treatment discontinuation because of the toxicity, and the CES1 rs71647871-A allele could partially elevate the risk of severe HFS in capecitabine-treated patients. Here, CES1 is linked to Hand-foot syndrome.